Abstract
In Vaud, Switzerland, the incidence of carcinoids based on 218 malignant and 215 benign cases rose from 19.6/106in 1974–85 to 28.2/106in 1986–97, more so among males and malignant neoplasms. Lung was the commonest site for malignant and large intestine for benign carcinoids. Sixty-eight (16%) carcinoids had another neoplasm. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Berner M (1993) Carcinoïdes digestifs et tumeurs malignes synchrones. Schweiz Med Wschr 123: 594–599
Doll R and Smith PG (1987) Comparison between registries: age-standardized rates. In: Cancer Incidence in Five Continents, Vol. IV, JAH Waterhouse, CS Muir, K Shanmugaratham, J Powell, D Peacham, S Whelan (eds), Lyon, International Agency for Research on Cancer, IARC Scient Publ 42: 634–637
Ederer F, Axtell MA and Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6: 101–121
Fiocca R, Rindi R, Capella C, Grimelius L, Polak JM, Schwartz TW, Yanaihara N and Solcia E (1987) Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosa-peptide immunoreactivites of rectal carcinoid tumours and related non-tumour cells. Reg Pep 17: 9–29
Keshgegian AA and Wheeler JE (1980) Estrogen receptor protein in malignant carcinoid tumor. Cancer 45: 293–296
Krenning EP, de Jong M, Kooij PPM, Breeman WAP, Bakker WH, de Herder WW, van Ejick CHJ, Kwekkeboom DJ, Jamar F, Pauwels S and Valkema R (1999) Radiolabeled somatostatin analogues for peptide receptor scintigraphy and radionuclide therapy. Ann Oncol 10: S23–S29
Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, Sundell G, Wallmark B, Watanabe T and Hakanson R (1986) Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation. Gastroenterology 90: 391–399
Läuffer JM, Zhang T and Modlin IM (1999) Review article: current status of gastrointestinal carcinoids. Aliment Pharmacol Ther 13: 271–287
Levi F, La Vecchia C, Franceschi S and Te VC (1991) Morphologic analysis of digestive cancers from the Registry of Vaud, Switzerland. Br J Cancer 63: 567–572
Levi F, Randimbison L, Te VC, Franceschi S and La Vecchia C (1992) Trends in cancer survival in Vaud, Switzerland. Eur J Cancer 28: 1490–1495
Levi F, Randimbison L, Franceschi S and La Vecchia C (1993) Descriptive epidemiology of malignant carcinoids in the Swiss Canton of Vaud. Int J Cancer 53: 1036–1037
Levi F, Te VC, Randimbison L and La Vecchia C (1997) Statistics from the Registry of the Canton of Vaud, Switzerland, 1988–92. In: Cancer Incidence in Five Continents, Vol VII. Parkin DM, Whelan S, Ferlay J, Raymond L, Young J. (eds). Lyon: International Agency for Research on Cancer. IARC Scien Pub 143: 674–677
Mignon M, Lehy T, Bonnefond A, Ruszniewski P, Labeille D and Bonfils S (1987) Development of gastric argyrophil carcinoid tumours in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term secretory treatment. Cancer 59: 1959–1962
Modlin IM and Sandor A (1997) An analysis of 8305 cases of carcinoid tumors. Cancer 79: 813–829
Modlin I, Zucker K, Zdon M, Sussman J and Adrian T (1988) Characteristics of the spontaneous gastric endocrine tumor of Mastomys. J Surg Res 44: 205–215
Modlin I, Bilchik,, Nilsson O and Goldenring J (1989) Enterochromaffin-like cell tumor induction in Mastomys by insurmontable H2 receptor blokade. Res Clin Forums 12: 59–74
Modlin IM, Lawton GP, Tang LH, Geibel J, Abraham R and Darr U (1994) The Mastomys gastric carcinoid: aspects of enterochromaffin-like cell function. Digestion 55: 31–37
Newton JN, Swerdlow AJ, dos Santos Silva IM, Vessey MP, Grahame-Smith DG, Primatesta P and Reynolds DJM (1994) The epidemiology of carcinoid tumours in England and Scotland. Br J Cancer 70: 939–942
Rindi GR, Bordi C, Rappel S, La Rosa S, Stolte M and Solcia E (1996) Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology and behavior. World J Surg 20: 168–172
Solcia E, Kloppel G and Sobin LH (2000a) Histological typing of endocrine tumors. WHO Classification of Endocrine Tumours. Springer-Verlag: Berlin, 160
Solcia E, Rindi G, LaRosa S and Capella C (2000b) Morphological, molecular, and prognostic aspects of gastric endocrine tumors. Microsc Res Tech 48: 339–348
Thompson GB, Van Heerden JA, Martin JK, Schutt AJ, Ilstrup DM and Carney JA (1985) Carcinoid tumours of the gastrointestinal tract: presentation, management and prognosis. Surgery 98: 1054–1062
World Health Organization (1976) International Classification of Diseases for Oncology, ICD-O. Geneva: World Health Organisation, p. 131
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Levi, F., Te, VC., Randimbison, L. et al. Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974–97. Br J Cancer 83, 952–955 (2000). https://doi.org/10.1054/bjoc.2000.1394
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1394
Keywords
This article is cited by
-
Epidemiology and management of neuroendocrine neoplasms of unknown origin: an overview
Journal für Klinische Endokrinologie und Stoffwechsel (2023)
-
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study
Endocrine (2021)
-
Pulmonary carcinoid tumours: incidence, histology, and surgical outcome. A population-based study
General Thoracic and Cardiovascular Surgery (2020)
-
Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
Reviews in Endocrine and Metabolic Disorders (2017)
-
Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms
Endocrine (2017)